Lv1
10 积分 2023-08-09 加入
Neoadjuvant chemoimmunotherapy for laryngeal preservation in locally advanced hypopharyngeal cancer
25天前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
25天前
已完结
Anti-PD-1 immunotherapy – Pembrolizumab current clinical trials for advanced head and neck cancer: A mapping systematic study
26天前
已完结
Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab
27天前
已完结
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial
27天前
已完结
Eps8 expression is significantly lower in p16+ head and neck squamous cell carcinomas (HNSCCs) compared with p16− HNSCCs
1个月前
已完结
Nivolumab for recurrent squamous-cell carcinoma of the head and neck
1个月前
已完结
Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma
1个月前
已完结
p16INK4a Expression, human papillomavirus, and survival in head and neck cancer
1个月前
已完结
Global Epidemiology of Head and Neck Cancers: A Continuing Challenge
1个月前
已完结
皖公网安备34019202002308
